ERBB2 and cholangiocarcinoma: Yoshikawa and colleagues reviewed 236 cases of surgically resected cholangiocarcinoma and reported a 0.9 and 8.5 % incidence of HER2/neu expression in intra- and extrahepatic cholangiocarcinoma, respectively.